Immunogenicity of a virosomally-formulated Plasmodium falciparum GLURP-MSP3 chimeric protein-based malaria vaccine candidate in comparison to adjuvanted formulations

BACKGROUND: In clinical trials, immunopotentiating reconstituted influenza virosomes (IRIVs) have shown great potential as a versatile antigen delivery platform for synthetic peptides derived from Plasmodium falciparum antigens. This study describes the immunogenicity of a virosomally-formulated rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamborrini, Marco, Stoffel, Sabine A, Westerfeld, Nicole, Amacker, Mario, Theisen, Michael, Zurbriggen, Rinaldo, Pluschke, Gerd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3265551/
https://www.ncbi.nlm.nih.gov/pubmed/22166048
http://dx.doi.org/10.1186/1475-2875-10-359

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3265551/
https://www.ncbi.nlm.nih.gov/pubmed/22166048
http://dx.doi.org/10.1186/1475-2875-10-359

Ejemplares similares